When receiving a karyotype or CGH-array result mentioning an anomaly on chromosome 4, the first difficulty is understanding what this concretely means. Chromosome 4 is not chromosome 21: complete trisomies of this chromosome are incompatible with a full-term pregnancy. Therefore, we almost always talk about partial trisomies, duplications of a segment of the short arm (4p) or the long arm (4q), with very variable consequences.
CGH-array and chromosome 4: how new analyses change the diagnosis
Before the widespread use of high-resolution molecular genetics techniques, most partial anomalies of chromosome 4 went unnoticed. A standard karyotype may show a visible rearrangement, but it misses microduplications of a few megabases.
Recommended read : Discover the secret of the Nikasil cylinder: Everything you need to know about this revolutionary treatment!
Since the mid-2010s, CGH-array (comparative genomic hybridization on microarray) has changed the game. A 2022 review reports a recent increase in diagnoses of partial trisomies involving chromosome 4, directly linked to the dissemination of these techniques in Europe and North America. Duplications 4p or 4q that remained invisible are now identified, sometimes in children presenting with moderate developmental delay without any other indicative signs.
When a geneticist prescribes a CGH-array after an assessment of psychomotor delay or an atypical prenatal ultrasound, they obtain a fine mapping of the genome. The duplicated segment on chromosome 4 is precisely located, and it is this location that guides the follow-up.
See also : Everything You Need to Know About the Dimensions of Old Velux for a Successful Installation
To better understand the specifics of chromosome 4 in trisomy, it is essential to understand that two duplications of different sizes or positions on the same chromosome produce distinct clinical pictures.
Partial trisomy 4p and 4q: clinical pictures not to be confused
Chromosome 4 is one of the largest human chromosomes. A duplication on the short arm (4p) does not affect the same genes as a duplication on the long arm (4q), and the impacts differ significantly.
Duplications of the short arm 4p
4p duplications are associated with a set of signs that may include:
- Facial features (prominent forehead, wide nasal bridge), often noted at birth by the pediatrician or neonatologist
- Variable intensity psychomotor developmental delay, ranging from a simple delay in acquisitions to a more marked deficit depending on the size of the duplicated segment
- Congenital heart defects requiring early cardiological assessment, sometimes as early as the prenatal period if the ultrasound showed an anomaly
- Growth delay that manifests mainly in the early years of life
Duplications of the long arm 4q
4q duplications present a partially different profile. Skeletal anomalies, neonatal feeding difficulties, and language delay are frequently observed. The severity depends on the segment involved: a distal duplication (towards the end of the long arm) does not have the same impact as a proximal duplication (near the centromere).
The size and exact position of the duplicated segment determine the prognosis, which explains why older brochures, written from small case series, sometimes provide a too homogeneous view of this condition.
Expanded non-invasive prenatal screening: the new challenge of genetic counseling
Non-invasive prenatal screening (NIPS), initially designed to detect trisomies 21, 18, and 13, has expanded. Since 2020, several teams have reported an increased detection of rare aneuploidies involving chromosome 4 when NIPS covers the entire fetal genome.
The concrete problem is as follows: a partial duplication of chromosome 4 is identified in a fetus, while the ultrasound shows nothing alarming. The couple faces a result of uncertain significance. The geneticist must then propose an invasive procedure (amniocentesis) to confirm and specify the anomaly, while explaining that clinical variability is wide.
This scenario is becoming increasingly frequent. It requires prenatal diagnostic teams to have updated databases on the genotype-phenotype correlations of chromosome 4, and families to benefit from specialized genetic counseling before making any decisions.
Early management and functional prognosis of children with a chromosome 4 anomaly
Feedback from national congenital malformation registries and clinical series published in recent years shows an encouraging trend. The functional prognosis for children with partial trisomy or duplication of chromosome 4 is improving, and this improvement is less about genetics itself than about the structuring of care.
The intervention axes that make a difference on a daily basis:
- A systematic cardiological and orthopedic assessment in the first weeks of life, to treat operable malformations early
- Rapid referral to psychomotor therapy and speech therapy, ideally before the age of one, to stimulate motor and language acquisitions
- Access to early intervention programs, which allow for more frequent schooling in regular settings than what was described in older publications
Feedback varies among teams and regions regarding the optimal rhythm of follow-up assessments, but the general trend is towards coordinated multidisciplinary support as soon as the diagnosis is made.
What emerges from recent data is that the precision of genetic diagnosis (exact location of the duplicated segment, size in megabases, presence or absence of a mosaic state) allows for anticipating the specific needs of each child. A follow-up based on generic protocols for more well-known trisomies is not sufficient: chromosome 4 requires an individualized reading of the result, translated into a concrete care plan by a team that knows these rare anomalies.